Short answer
VIEMED HEALTHCARE, INC. (VMD) filed its Q3 2026 10-Q quarterly report on Nov 4, 2026 for the quarter ended Sep 30, 2026. Quarterly revenue was $81M (up 12.2% year over year) with net income of $5M.
Q3 2026 key financials · XBRL
- Revenue
- $81M
- +12.2% YoY · +3.3% QoQ
- Net income
- $5M
- +32.0% YoY · +67.8% QoQ
- Operating margin
- 8.6%
- Gross margin
- 57.3%
- EPS (diluted)
- $0.11
- +22.2% YoY · +57.1% QoQ
Source: XBRL data from the VIEMED HEALTHCARE, INC. (VMD) Q3 2026 10-Q on SEC EDGAR. USD.
VIEMED HEALTHCARE, INC. Q3 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- Revenue $80.7M, up 12.2% YoY from $71.9M, driven by sleep therapy, respiratory care and women’s health
- Net income margin 5.9% vs 5.0% YoY, operating margin 8.6% vs 7.8%
- Best segment: equipment and supply sales $19.4M, up 23.7%; worst: ventilator rentals $37.5M, up 7.4%
- Cash $9.7M at September 30 vs $13.5M at December 31; nine-month operating cash flow $35.5M
- Capital deployment: $23.8M equipment purchases, $7.7M share repurchases, $7.6M term-loan payments
- Headwinds: reimbursement pressure, CMS coverage criteria, potential future tariffs and competitive bidding changes
Risk Factors
- No material risk-factor changes from the December 31, 2025 Form 10-K
- Carried-forward business, financial-condition, and future-results risks remain applicable
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other VIEMED HEALTHCARE, INC. quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.